Skip to main content

Table 8 Fluctuations in MAP (mmHg) and SpO2 (%) among the study participants

From: Comparative study of the efficacy and safety of remimazolam and midazolam for general anesthesia in elderly patients: a randomized controlled trial

Group

T7 (MAP)

T7 (SpO2)

T10 (SpO2)

Remimazolam

115.3 ± 13.56

96.52 ± 2.934

96.96 ± 2.241

Midazolam

109.84 ± 13.20

98.02 ± 1.813

97.98 ± 2.564

p value

0.048

0.004

0.041